| Keith J Frederick, DO | |
|
1050 W 10th St, Rolla, MO 65401-2905 | |
| (573) 364-5633 | |
| (573) 426-5314 |
| Full Name | Keith J Frederick |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 43 Years |
| Location | 1050 W 10th St, Rolla, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366552762 | NPI | - | NPPES |
| 242256303 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | R4D88 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Phelps County Regional Medical Center | Rolla, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pcrmc Medical Group, Inc | 1557454063 | 90 |
News Archive
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the Massachusetts General Hospital (MGH), in collaboration with Novelos, was awarded a $950,371 competitive grant by the National Institutes of Health (NIH) to study two Novelos compounds – NOV-002 and NOV-205 – for the mitigation and treatment of radiation-induced pulmonary injury.
Exposure to loud noise, such as a firecracker or an ear-splitting concert, is the most common preventable cause of hearing loss. Research suggests that 12% or more of the world population is at risk for noise-induced loss of hearing.
New research from The Scripps Research Institute may give scientists a chance to target tumors before they metastasize.
MichBio, the statewide trade association dedicated to driving the growth of Michigan's biosciences industry, has launched a 2010 "It Pays to Belong" campaign to broaden and increase awareness of MichBio's member services and mission.
Researchers from Queen Mary University of London, have identified a protein that may represent a novel therapeutic target for the treatment of pancreatic cancer.
› Verified 7 days ago
| Entity Name | Phelps County Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891766051 PECOS PAC ID: 2860391158 Enrollment ID: O20040106000405 |
News Archive
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the Massachusetts General Hospital (MGH), in collaboration with Novelos, was awarded a $950,371 competitive grant by the National Institutes of Health (NIH) to study two Novelos compounds – NOV-002 and NOV-205 – for the mitigation and treatment of radiation-induced pulmonary injury.
Exposure to loud noise, such as a firecracker or an ear-splitting concert, is the most common preventable cause of hearing loss. Research suggests that 12% or more of the world population is at risk for noise-induced loss of hearing.
New research from The Scripps Research Institute may give scientists a chance to target tumors before they metastasize.
MichBio, the statewide trade association dedicated to driving the growth of Michigan's biosciences industry, has launched a 2010 "It Pays to Belong" campaign to broaden and increase awareness of MichBio's member services and mission.
Researchers from Queen Mary University of London, have identified a protein that may represent a novel therapeutic target for the treatment of pancreatic cancer.
› Verified 7 days ago
| Entity Name | Cedar County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619090404 PECOS PAC ID: 7315841129 Enrollment ID: O20040120000314 |
News Archive
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the Massachusetts General Hospital (MGH), in collaboration with Novelos, was awarded a $950,371 competitive grant by the National Institutes of Health (NIH) to study two Novelos compounds – NOV-002 and NOV-205 – for the mitigation and treatment of radiation-induced pulmonary injury.
Exposure to loud noise, such as a firecracker or an ear-splitting concert, is the most common preventable cause of hearing loss. Research suggests that 12% or more of the world population is at risk for noise-induced loss of hearing.
New research from The Scripps Research Institute may give scientists a chance to target tumors before they metastasize.
MichBio, the statewide trade association dedicated to driving the growth of Michigan's biosciences industry, has launched a 2010 "It Pays to Belong" campaign to broaden and increase awareness of MichBio's member services and mission.
Researchers from Queen Mary University of London, have identified a protein that may represent a novel therapeutic target for the treatment of pancreatic cancer.
› Verified 7 days ago
| Entity Name | Pcrmc Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124237227 PECOS PAC ID: 1557454063 Enrollment ID: O20070829000437 |
News Archive
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the Massachusetts General Hospital (MGH), in collaboration with Novelos, was awarded a $950,371 competitive grant by the National Institutes of Health (NIH) to study two Novelos compounds – NOV-002 and NOV-205 – for the mitigation and treatment of radiation-induced pulmonary injury.
Exposure to loud noise, such as a firecracker or an ear-splitting concert, is the most common preventable cause of hearing loss. Research suggests that 12% or more of the world population is at risk for noise-induced loss of hearing.
New research from The Scripps Research Institute may give scientists a chance to target tumors before they metastasize.
MichBio, the statewide trade association dedicated to driving the growth of Michigan's biosciences industry, has launched a 2010 "It Pays to Belong" campaign to broaden and increase awareness of MichBio's member services and mission.
Researchers from Queen Mary University of London, have identified a protein that may represent a novel therapeutic target for the treatment of pancreatic cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keith J Frederick, DO 1050 W 10th St, Attn: Executive Director Of Physician Clinics, Rolla, MO 65401 Ph: (573) 458-3451 | Keith J Frederick, DO 1050 W 10th St, Rolla, MO 65401-2905 Ph: (573) 364-5633 |
News Archive
Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the Massachusetts General Hospital (MGH), in collaboration with Novelos, was awarded a $950,371 competitive grant by the National Institutes of Health (NIH) to study two Novelos compounds – NOV-002 and NOV-205 – for the mitigation and treatment of radiation-induced pulmonary injury.
Exposure to loud noise, such as a firecracker or an ear-splitting concert, is the most common preventable cause of hearing loss. Research suggests that 12% or more of the world population is at risk for noise-induced loss of hearing.
New research from The Scripps Research Institute may give scientists a chance to target tumors before they metastasize.
MichBio, the statewide trade association dedicated to driving the growth of Michigan's biosciences industry, has launched a 2010 "It Pays to Belong" campaign to broaden and increase awareness of MichBio's member services and mission.
Researchers from Queen Mary University of London, have identified a protein that may represent a novel therapeutic target for the treatment of pancreatic cancer.
› Verified 7 days ago
Alan D Heincker, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-5633 Fax: 573-202-2490 | |
Dr. Daniel O'loughlin, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1605 Martin Springs Dr Ste 330, Rolla, MO 65401 Phone: 573-458-6370 | |
Dr. Thomas Frederick Satterly Iii, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-5633 Fax: 573-202-2490 | |
Jay Patel, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1605 Martin Springs Dr, Rolla, MO 65401 Phone: 417-533-6560 | |
Theodore Nmi Koreckij, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-5633 Fax: 573-426-5314 | |
Mr. Michael Sterling Potter, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 Fax: 573-426-5314 |